All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Antithrombotic agents

Kengrexal

(cangrelor)

Uses, side effects, dosage information & price range

Chiesi Farmaceutici S.p.A.

About this medicine

Kengrexal, co-administered with acetylsalicylic acid (ASA), is indicated for the reduction of thrombotic cardiovascular events in adult patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) who have not received an oral P2Y12 inhibitor prior to the PCI procedure and in whom oral therapy with P2Y12 inhibitors is not feasible or desirable.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

CeprotinComposition: human protein CTakeda Manufacturing Austria AG
Price on RequestView Details →
Rivaroxaban Viatris (previously Rivaroxaban Mylan)Composition: rivaroxabanViatris Limited
Price on RequestView Details →
RapilysinComposition: reteplaseActavis Group PTC ehf
Price on RequestView Details →
ArixtraComposition: fondaparinux sodiumViatris Healthcare Limited
Price on RequestView Details →
IntegrilinComposition: eptifibatideGlaxoSmithKline Trading Services Limited
Price on RequestView Details →

Key Information

Salt / Composition

cangrelor

Category

Antithrombotic agents

Manufacturer

Chiesi Farmaceutici S.p.A.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.